DMD, dystrophin, 1756

N. diseases: 484; N. variants: 345
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0036529
Disease: Myocardial Diseases, Secondary
Myocardial Diseases, Secondary
0.310 GeneticVariation group BEFREE Familial dilated cardiomyopathy secondary to dystrophin splice site mutation. 20206892 2010
CUI: C0036529
Disease: Myocardial Diseases, Secondary
Myocardial Diseases, Secondary
0.310 Biomarker group CTD_human Systemic administration of micro-dystrophin restores cardiac geometry and prevents dobutamine-induced cardiac pump failure. 17440445 2007
CUI: C0036529
Disease: Myocardial Diseases, Secondary
Myocardial Diseases, Secondary
0.310 Therapeutic group CTD_human Combined deficiency of dystrophin and beta1 integrin in the cardiac myocyte causes myocardial dysfunction, fibrosis and calcification. 18340010 2008
CUI: C0036529
Disease: Myocardial Diseases, Secondary
Myocardial Diseases, Secondary
0.310 Therapeutic group CTD_human Systemic administration of micro-dystrophin restores cardiac geometry and prevents dobutamine-induced cardiac pump failure. 17440445 2007
CUI: C0036529
Disease: Myocardial Diseases, Secondary
Myocardial Diseases, Secondary
0.310 Therapeutic group CTD_human Intolerance to ß-blockade in a mouse model of δ-sarcoglycan-deficient muscular dystrophy cardiomyopathy. 20675662 2010
CUI: C0036529
Disease: Myocardial Diseases, Secondary
Myocardial Diseases, Secondary
0.310 Biomarker group CTD_human Combined deficiency of dystrophin and beta1 integrin in the cardiac myocyte causes myocardial dysfunction, fibrosis and calcification. 18340010 2008
CUI: C0036529
Disease: Myocardial Diseases, Secondary
Myocardial Diseases, Secondary
0.310 Biomarker group CTD_human Intolerance to ß-blockade in a mouse model of δ-sarcoglycan-deficient muscular dystrophy cardiomyopathy. 20675662 2010